DEF 14A

Company

KalVista Pharmaceuticals, Inc.

Filed

August 23, 2019

Period of Report

October 2, 2019

Accession Number

0001564590-19-032858

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →